| Drug Name: | Stanozolol (10418-03-8) |
|---|---|
| PubChem ID: | 25249 |
| SMILES: | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C |
| InchiKey: | LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 328.5 |
| LogP | : | 4.1181 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 48.91 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Dicumarol (66-76-2) | Bleeding | Antagonistic | Not understood | Anabolic steroids and anticoagulants |
| Warfarin (81-81-2) | Bleeding | Antagonistic | Not understood | Possible interaction of warfarin and stanozolol |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category